Blog

The financial sector has been one of the slowest areas of the stock market to recover from the COVID-19 pandemic. While the S&P 500 is now up by 7% for the year, the financial sector is still down

About two years ago, Aurora Cannabis (NYSE: ACB) was considered one of the most promising marijuana companies. The pot grower was only second to Canopy Growth (NYSE: CGC) in terms of market cap at

As the maker of the da Vinci robotic surgery suite, Intuitive Surgical (NASDAQ: ISRG) doesn't fit the mold of a traditional Warren Buffett stock. The company needs to spend a significant portion of

Vertex Pharmaceuticals (NASDAQ: VRTX) and Alexion Pharmaceuticals (NASDAQ: ALXN) are two major competitors in the healthcare sector, both of whom focus on developing drugs for rare diseases like

Comparing Illumina (NASDAQ: ILMN) with Exelixis (NASDAQ: EXEL) feels like a mismatch. The former is a dominant provider of genome sequencers serving as -- some might argue -- the foundation for the

Robinhood's trading platform is often associated with high-risk, speculative investments. And while there are arguably many bad-outlook or expensive investments on the Robinhood Top 100 list, there

COVID-19 has wreaked havoc on economies around the world and has upended many industries, including airlines, travel, and restaurants. In-store retail shopping has suffered as well, as social

A straightforward way of making money in the stock market is to load up on companies when they are trending up and sell them quickly when their results disappoint. Such a short-term strategy is so

More than half of workers 10 to 20 years from retirement (53%) say that determining how much they should save is their biggest retirement question, according to a report from the Empower Institute.

The neurology drug developer Biogen (NASDAQ: BIIB) reported its quarterly earnings on Oct. 21 , stating that its total revenue fell by 6% compared to 2019, reaching $3.37 billion for FY 2020. This

The race to develop lifesaving COVID-19 treatments recently took a surprise turn for the worse. Eli Lilly's (NYSE: LLY) COVID-19 treatment candidate, an antibody called LY-CoV555, flopped in a

There have now been more than 43 million confirmed cases of COVID-19 around the world, and experts are already warning of a substantial third wave of cases in many countries. It's safe to say that

ONEOK's (NYSE: OKE) operational and financial results bounced back big time during the third quarter as its natural gas liquids (NGL) volumes topped their pre-pandemic level. Fueling the brisk

Apple (NASDAQ: AAPL) has acquired Vilynx, a company focused on using computer vision and artificial intelligence to analyze a video's audio, visual, and related text elements to understand the

You'll probably rely on your Social Security benefits to pay the bills in retirement. In fact, those benefits may even be your sole source of income. That's why understanding when you're allowed to

When it comes to winning biotech stocks this year, coronavirus vaccine developers automatically come to many investors' minds. However, one of the top-performing stocks in the sector is Northwest

The digital health sector is expected to grow with a compound annual growth rate (CAGR) of close to 30% to reach a valuation of almost $640 billion by 2026, according to market research firm

Investing in 2020 should really come with an instruction manual, because we've seen the stock market do things that were never believed to be possible. We witnessed the CBOE Volatility Index log its

Ford Motor Company (NYSE: F) will report its third-quarter results after the bell on Wednesday, Oct. 28. Will it outperform Wall Street's expectations? 

On average, Wall Street analysts polled by

Fastly (NYSE: FSLY) has been all the rage this year. The content delivery network (CDN) and edge computing specialist has been on a tear, with its stock gaining more than 500%. Earlier this month

For a while, the U.S. late-stage clinical trials of coronavirus vaccine candidates developed by AstraZeneca (NYSE: AZN) and Johnson & Johnson (NYSE: JNJ) were in limbo. Both big drugmakers reported

Did you know that the government wants to give you a lot of money toward your retirement? In fact, depending on your financial situation and the amount you're willing to invest for your future, you

DexCom (NASDAQ: DXCM) rebounded quickly from the coronavirus-fueled market meltdown earlier this year. But while its shares are up more than 70% year to date, the stock has mostly been in a holding

It's been a record-breaking year for Wall Street in many respects. The CBOE Volatility Index reached its highest-ever reading, West Texas Intermediate crude futures plunged deeply (but briefly) into

Image source: The Motley Fool.

FireEye (NASDAQ: FEYE)Q3 2020 Earnings CallOct 27, 2020, 5:00 p.m. ET

Operator

Continue reading

Source Fool.com